These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12787513)

  • 21. Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics.
    Lu MC; Hsieh SC; Lai NS; Li KJ; Wu CH; Yu CL
    Clin Exp Rheumatol; 2007; 25(5):716-21. PubMed ID: 18078619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Capillary microscopy in connective tissue diseases].
    Forster A; Brühlmann P
    Dtsch Med Wochenschr; 2001 Nov; 126(45):1285. PubMed ID: 11729821
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative evaluation of antinuclear factor tests in rheumatic disorders.
    Willkens RF; Decker JL; Wilske KR
    Med Clin North Am; 1968 May; 52(3):559-65. PubMed ID: 4385202
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoantibodies, detection methods and panels for diagnosis of Sjögren's syndrome.
    Shen L; Suresh L
    Clin Immunol; 2017 Sep; 182():24-29. PubMed ID: 28390965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autoantibodies, diagnostic and prognostic markers of rheumatoid polyarthritis].
    Sibilia J
    Presse Med; 2000 Oct; 29(31):1723-30. PubMed ID: 11094620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-GM1 and anti-sulfatide antibodies in patients with systemic lupus erythematosus, Sjögren's syndrome, mixed cryoglobulinemia and idiopathic systemic vasculitis.
    Alpa M; Ferrero B; Cavallo R; Perna A; Naretto C; Gennaro M; Di Simone D; Bellizia L; Mansouri M; Rossi D; Modena V; Giachino O; Sena LM; Roccatello D
    Clin Exp Rheumatol; 2007; 25(4):556-62. PubMed ID: 17888211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.
    Savige JA; Chang L; Wilson D; Buchanan RR
    Rheumatol Int; 1996; 16(3):109-14. PubMed ID: 8893375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of antinuclear antibodies in systemic rheumatic diseases.
    Hietarinta M; Lassila O
    Ann Med; 1996 Aug; 28(4):283-91. PubMed ID: 8862680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [How can one miss an autoimmune disease?].
    Papo T
    Rev Mal Respir; 2006 Dec; 23(6):754-6. PubMed ID: 17886353
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a protein.
    Coppo P; Henry-Dessailly I; Rochette J; Lok C; Buendia B; Lassoued K
    Eur J Intern Med; 2013 Dec; 24(8):868-71. PubMed ID: 24184038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
    J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
    Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
    Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antineutrophil cytoplasm antibody: positivity and clinical correlation.
    Martínez Téllez G; Torres Rives B; Rangel Velázquez S; Sánchez Rodríguez V; Ramos Ríos MA; Fuentes Smith LE
    Reumatol Clin; 2015; 11(1):17-21. PubMed ID: 24913965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recently characterised autoantibodies and their clinical significance.
    Sturgess A
    Aust N Z J Med; 1992 Jun; 22(3):279-89. PubMed ID: 1497555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of laboratory tests in the diagnosis of SLE.
    Egner W
    J Clin Pathol; 2000 Jun; 53(6):424-32. PubMed ID: 10911799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antinuclear factors. Demonstration and clinico-diagnostic significance].
    Maas D
    Med Klin; 1969 Jul; 64(29):1302-7. PubMed ID: 4184549
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic Lupus Erythematosus, Sjögren Syndrome, and Mixed Connective Tissue Disease in Children and Adolescents.
    Tarvin SE; O'Neil KM
    Pediatr Clin North Am; 2018 Aug; 65(4):711-737. PubMed ID: 30031495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z; Ren Y; Liu D; Lin F; Liang Y
    APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
    Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.